The DOI matches its Crossref record; 288 of the 288 references it cites were found in a registry or an index.
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–288 of 288
Chakravarti, N., Myers, J. N., & Aggarwal, B. B. (2006) · International Journal of Cancer · doi:10.1002/ijc.21967 · Cited by 115
Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines
Fossey, S. L., Bear, M. D., Kisseberth, W. C., Pennell, M. L., & London, C. A. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-125 · Cited by 115
Kim, C.-S., Park, W.-H., Park, J.-Y., Kang, J., Kim, M.-O., Kawada, T., Yoo, H., Han, I., & Yu, R. (2004) · Journal of Medicinal Food · doi:10.1089/jmf.2004.7.267 · Cited by 113
Chan, K. S., Sano, S., Kataoka, K., Abel, E. L., Carbajal, S., Beltrán, L., Clifford, J. L., Peavey, M. C., Shen, J., & DiGiovanni, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210726 · Cited by 112
Zhang, C., Li, B., Zhang, X., Hazarika, P., Aggarwal, B. B., & Duvic, M. A. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.86 · Cited by 112
BCR–ABL activates STAT3 via JAK and MEK pathways in human cells
Coppo, P., Flamant, S., Mas, V. M., Jarrier-Gaillard, P., Guillier, M., Bonnet, M., Lacout, C., Guilhot, F., Vainchenker, W., & Turhan, A. G. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06161.x · Cited by 110
Dalwadi, H., Krysan, K., Heuzé‐Vourc'h, N., Dohadwala, M., Elashoff, D. A., Sharma, S. P., Cacalano, N. A., Lichtenstein, A. K., & Dubinett, S. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1205 · Cited by 110
Pandey, M. K., Sung, B., & Aggarwal, B. B. (2009) · International Journal of Cancer · doi:10.1002/ijc.25059 · Cited by 108
Leeman‐Neill, R. J., Wheeler, S., Singh, S. V., Thomas, S. M., Seethala, R. R., Neill, D. B., Panahandeh, M. C., Hahm, E., Joyce, S. C., Sen, M., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp211 · Cited by 108
Singh, S. V., Choi, S., Zeng, Y., Hahm, E., & Xiao, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0120 · Cited by 107
Effect of caffeic acid on tert-butyl hydroperoxide-induced oxidative stress in U937
Nardini, M., Pisu, P., Gentili, V., Natella, F., Di, M., Piccolella, F., & Scaccini, C. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00180-4 · Cited by 106
Wang, Y., Chan, F. L., Chen, S., & Leung, L. K. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.12.014 · Cited by 106
Yu, C., Jove, R., & Burakoff, S. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5206 · Cited by 105
Miscia, S., Marchisio, M., Grilli, A., Valerio, V. D., Centurione, L., Sabatino, G., Garaci, F. G., Zauli, G., Bonvini, E., & Baldassarre, A. D. (2002) · PubMed · Cited by 102
Suiqing, C., Min, Z., & Lirong, C. (2005) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2005.tb00906.x · Cited by 102
Autocrine-mediated Activation of STAT3 Correlates with Cell Proliferation in Breast Carcinoma Lines
Li, L., & Shaw, P. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109962200 · Cited by 102
Signal transducer and activator of transcription 3 inhibitors: a patent review
Page, B. D. G., Ball, D. P., & Gunning, P. T. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.539205 · Cited by 102
Lu, Z., Jin, Y., Qiu, L., Lai, Y., & Pan, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.09.006 · Cited by 101
Laird, A., Li, G., Moss, K. G., Blake, R. A., Broome, M. A., Cherrington, J. M., & Mendel, D. B. (2003) · PubMed · Cited by 101
The JAK kinases: Not just another kinase drug discovery target
Wilks, A. F. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.07.020 · Cited by 97
Gotoh, A., Takahira, H., Mantel, C., Litz-Jackson, S., Boswell, H. S., & Broxmeyer, H. (1996) · Blood · doi:10.1182/blood.v88.1.138.138 · Cited by 97
Tacke, R., Tosello-Trampont, A., Nguyen, V., Mullins, D. W., & Hahn, Y. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.217653 · Cited by 96
Cardiotrophin-1 Increases Angiotensinogen mRNA in Rat Cardiac Myocytes Through STAT3
Fukuzawa, J., Booz, G. W., Hunt, R. A., Shimizu, N., Karoor, V., Baker, K. M., & Dostal, D. E. (2000) · Hypertension · doi:10.1161/01.hyp.35.6.1191 · Cited by 96
Ivanov, V. N., Ronai, Z. A., & Ma, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108233200 · Cited by 95
Dvorak, K., Chavarria, M., Payne, C. M., Ramsey, L., Crowley-Weber, C. L., Dvorakova, B., Dvořák, B., Bernstein, H., Holubec, H., Sampliner, R. E., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0483 · Cited by 92
Feng, D. Y. (2001) · World Journal of Gastroenterology · doi:10.3748/wjg.v7.i1.33 · Cited by 91
Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein
Fletcher, S., Drewry, J. A., Shahani, V. M., Page, B. D. G., & Gunning, P. T. (2009) · Biochemistry and Cell Biology · doi:10.1139/o09-044 · Cited by 90
STAT 3 as a Target for Cancer Drug Discovery
Costantino, L., & Barlocco, D. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783955464 · Cited by 89
Si, J., & Collins, S. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2509 · Cited by 88
Gatsios, P., Terstegen, L., Schliess, F., Häussinger, D., Kerr, I. M., Heinrich, P. C., & Graeve, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.22962 · Cited by 85
Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene
Song, Y., Lu, Q., Song, S., Chen, L., Zhang, Y., Yuan, G., Zhang, H., Xia, Q., Hu, M., Yu, M., et al. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.04.031 · Cited by 84
Small Molecule Inhibitors of STAT3 for Cancer Therapy
Zhao, M. L., Jiang, B., & Gao, F. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796957284 · Cited by 82
Rationally Designed Inhibitors Identify STAT3 N-Domain as a Promising Anticancer Drug Target
Timofeeva, O. A., Gaponenko, V., Lockett, S., Tarasov, S. G., Jiang, S., Michejda, C. J., Perantoni, A. O., & Tarasova, N. I. (2007) · ACS Chemical Biology · doi:10.1021/cb700186x · Cited by 80
Mankan, A. K., & Greten, F. R. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.601739 · Cited by 80
Masciocchi, D., Gelain, A., Villa, S., Meneghetti, F., & Barlocco, D. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.22 · Cited by 80
Zorzi, E., & Bonvini, P. (2011) · Cancers · doi:10.3390/cancers3043921 · Cited by 80
Celastrol Potentiates Radiotherapy by Impairment of DNA Damage Processing in Human Prostate Cancer
Dai, Y., DeSano, J. T., Meng, Y., Ji, Q., Ljungman, M. E., Lawrence, T. S., & Xu, L. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.03.057 · Cited by 79
Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma
Liu, T., Zhang, M., Zhang, H., Sun, C., & Deng, Y. (2008) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-008-0625-9 · Cited by 76
Duan, Z., Ames, R. Y., Ryan, M. B., Hornicek, F. J., Mankin, H. J., & Seiden, M. V. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0785-8 · Cited by 75
Boehm, A. L., Sen, M., Seethala, R. S., Gooding, W. E., Freilino, M. L., Wong, S. M. Y., Wang, S., Johnson, D. E., & Grandis, J. R. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.044636 · Cited by 74
Macha, M. A., Matta, A., Chauhan, S., Siu, K. W. M., & Ralhan, R. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq278 · Cited by 74
The Chalcone Butein fromRhus vernicifluashows Antifibrogenic Activity
Lee, S. H., Nan, J., Zhao, Y. Z., Woo, S. W., Park, E., Kang, T., Seo, G. S., Kim, Y., & Sohn, D. H. (2003) · Planta Medica · doi:10.1055/s-2003-45143 · Cited by 72
Jang, E.-H., Moon, J.-S., Ko, J. H., Ahn, C.-W., Lee, H.-H., Shin, J.-K., Park, C., & Kang, J.-H. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.60 · Cited by 71
Novak, U., Mui, A., Miyajima, A., & Paradiso, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.31.18350 · Cited by 71
Nardini, M., Leonardi, F., Scaccini, C., & Virgili, F. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00515-3 · Cited by 70
Nardini, M., Scaccini, C., Packer, L., & Virgili, F. (2000) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00009-x · Cited by 69
Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2
Steinman, R. A., Wentzel, A. L., Lu, Y., Stehle, C. J., & Grandis, J. R. (2003) · Oncogene · doi:10.1038/sj.onc.1206523 · Cited by 69
Inhibiting aberrant Stat3 function with molecular therapeutics: a progress report
Haftchenary, S., Avadisian, M., & Gunning, P. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328341185b · Cited by 68
Cao, D., Tal, T. L., Graves, L. M., GILMOUR, I. J., Linak, W. P., REED, W. A., Bromberg, P. A., & Samet, J. M. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00204.2006 · Cited by 68
Moran, D. M., Mattocks, M. A., Cahill, P. A., Koniaris, L. G., & McKillop, I. H. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.04.022 · Cited by 65
Egloff, A. M., & Grandis, J. R. (2009) · Journal of Oncology · doi:10.1155/2009/896407 · Cited by 64
Role of STAT3 in Transformation and Drug Resistance in CML
Nair, R. R., Tolentino, J. H. G., & Hazlehurst, L. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00030 · Cited by 63
Ohtani, N., Yamakoshi, K., Takahashi, A., & Hara, E. (2010) · Cell Division · doi:10.1186/1747-1028-5-1 · Cited by 62
Kira, M., Sano, S., Takagi, S., Yoshikawa, K., Takeda, J., & Itami, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110795200 · Cited by 61
Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells
Coppo, P., Dusanter‐Fourt, I., Millot, G. A., Nogueira, M. M., Dugray, A., Bonnet, M. L., Mitjavila‐Garcia, M. T., Pesteur, D. L., Guilhot, F., Vainchenker, W., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206607 · Cited by 60
Percario, Z. A., Olivetta, E., Fiorucci, G., Mangino, G., Peretti, S., Romeo, G., Affabris, E., & Federico, M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403161 · Cited by 60
Burger, R., Gouill, S. L., Tai, Y., Shringarpure, R., Tassone, P., Neri, P., Podar, K., Catley, L. P., Hideshima, T., Chauhan, D., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0149 · Cited by 60
Bard, J. D., Gélébart, P., Anand, M., Zak, Z., Hegazy, S. A., Amin, H. M., & Lai, R. L. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080982 · Cited by 59
Multiple reasons for an inefficient STAT1 response upon IL-6-type cytokine stimulation
Haan, S., Keller, J. F., Behrmann, I., Heinrich, P. C., & Haan, C. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.010 · Cited by 59
Aziz, M. H., Manoharan, H. T., Sand, J. M., & Verma, A. K. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20356 · Cited by 57
Yin, W., Cheepala, S., Roberts, J. N., Chan, K. S., DiGiovanni, J., & Clifford, J. L. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-15 · Cited by 56
Takahashi, T., Fukuda, K., Pan, J., Kodama, H., Sano, M., Makino, S., Katō, T., Manabe, T., & Ogawa, S. (1999) · Circulation Research · doi:10.1161/01.res.85.10.884 · Cited by 56
Lack of toxicity of a STAT3 decoy oligonucleotide
Sen, M., Tosca, P. J., Zwayer, C., Ryan, M. J., Johnson, J. D., Knostman, K. A. B., Giclas, P. C., Peggins, J. O., Tomaszewski, J. E., McMurray, T. P., et al. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0823-6 · Cited by 53
Carl, V. S., Gautam, J., Comeau, L., & Smith, M. F. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003526 · Cited by 52
Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation
Liu, Y., Lv, L., Xiao, W., Gong, C., Yin, J., Wang, D., & Sheng, H. (2011) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-011-0382-7 · Cited by 50
STAT1 and STAT3 in Tumorigenesis: Two Sides of the Same Coin?
Jr., R. H. B. (2009) · CRC Press eBooks · doi:10.1201/9781498713764-13 · Cited by 50
CHOI, J., Ahn, M., PARK, C., Han, H., Kwon, S.-J., LEE, Y., & Kim, I. S. (2006) · Apmis · doi:10.1111/j.1600-0463.2006.apm_401.x · Cited by 49
Kurdi, M., & Booz, G. W. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21033 · Cited by 49
Zhang, Y., Sif, S., & DeWille, J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21356 · Cited by 47
Activation of Stat3 in renal tumors.
Guo, C. C., Yang, G., Khun, K., Kong, X., Levy, D. E., Lee, P., & Melamed, J. (2009) · PubMed Central · Cited by 47
Aizu, E., Nakadate, T., Yamamoto, S., & Kato, R. (1986) · Carcinogenesis · doi:10.1093/carcin/7.11.1809 · Cited by 42
Swiatek-Machado, K., Mieczkowski, J., Ellert‐Miklaszewska, A., Świerk, P., Fokt, I., Szymański, S., Skóra, S., Szeja, W., Grynkiewicz, G., Lesyng, B., et al. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.20083 · Cited by 41
Lee, S. H., Seo, G. S., Kim, H. S., Woo, S. W., Ko, G., & Sohn, D. H. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.004 · Cited by 40
Bito, T., Sumita, N., Masaki, T., Shirakawa, T., Ueda, M., Yoshiki, R., TOKURA, Y., & Nishigori, C. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01084.x · Cited by 39
IL-9 Induces CCL11 Expression via STAT3 Signalling in Human Airway Smooth Muscle Cells
Yamasaki, A., Saleh, A. J., Koussih, L., Muro, S., Halayko, A. J., & GOUNNI, A. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009178 · Cited by 39
Pre-assembly of STAT4 with the human IFN-α/β receptor-2 subunit is mediated by the STAT4 N-domain
Tyler, D. R., Persky, M. E., Matthews, L. A., Chan, S., & Farrar, J. D. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.10.006 · Cited by 39
LIGHT, a member of the TNF superfamily, activates Stat3 mediated by NIK pathway
Nadiminty, N., Chun, J. Y., Hu, Y., Dutt, S. S., Lin, X., & Gao, A. C. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.119 · Cited by 34
T40214/PEI complex: A potent therapeutics for prostate cancer that targets STAT3 signaling
Weerasinghe, P., Li, Y., Guan, Y., Zhang, R., Tweardy, D. J., & Jing, N. (2008) · The Prostate · doi:10.1002/pros.20807 · Cited by 34
Negative regulation of TIMP1 is mediated by transcription factor TWIST1
Haneji (2009) · International Journal of Oncology · doi:10.3892/ijo_00000327 · Cited by 34
Cai, L., Zhang, G., Tong, X., You, Q., An, Y., Wang, Y., Guo, L., Wang, T., Zhu, D., & Zheng, J. (2009) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2009.09.018 · Cited by 31
Kordula, T., Bugno, M., Goldstein, J. M., & Travis, J. W. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2719 · Cited by 24
Knockdown of stat3 expression by RNAi inhibits in vitro growth of human ovarian cancer
Zhao, S., Zhao, F., Zheng, J., Gao, L., Zhao, X., & Cui, M. (2011) · Radiology and Oncology · doi:10.2478/v10019-011-0013-8 · Cited by 24
STAT3 expression in salivary gland tumours
de Araújo, V. C., Furuse, C., Cury, P. R., ALTEMANI, A. M. D. A. M., & de Araújo, N. S. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.05.011 · Cited by 21
Muma, N. A., Singh, R. K., Vercillo, M. S., D’Souza, D. N., Zemaitaitis, B. W., García, F., Damjanoska, K. J., Zhang, Y., Battaglia, G., & de Kar, L. D. V. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.019 · Cited by 20
Stat3 as a molecular target in RNA interference-based treatment of oral squamous cell carcinoma
Nakashiro, K. (1994) · Oncology Reports · doi:10.3892/or_00000085 · Cited by 20
Cardioplegia and Diazoxide Modulate STAT3 Activation and DNA Binding
Hsieh, Y.-J., Wakiyama, H., Levitsky, S., & McCully, J. D. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.05.014 · Cited by 11
Burova, E., Gonchar, I. V., & Nikol'skiĭ, N. N. (2003) · PubMed · Cited by 8
Tacchini, L., Fusar-Poli, D., Sironi, M., Mantovani, A., & Bernelli‐Zazzera, A. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00164-4 · Cited by 7
Cited by
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Self-citationTewari, D., Patni, P., Bishayee, A., Sah, A. N., & Bishayee, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.008 · Cited by 642
Self-citationRegulatory circuits of T cell function in cancer
Speiser, D. E., Ho, P.-C., & Verdeil, G. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.80 · Cited by 566
The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G. (2015) · Molecules · doi:10.3390/molecules20022728 · Cited by 510
Self-citation
Metadata
- Authors
- Siveen, K. S., Sikka, S., Surana, R., Dai, X., Zhang, J., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 1845
- Issue
- 2
- Pages
- 136-154
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2102912734
- Cited by
- 634
- References
- 288
- FWCI
- 29.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.